CRISPR whole-genome screening identifies new necroptosis regulators and RIPK1 alternative splicing.

ABSTRACT: The necroptotic cell death pathway is a key component of human pathogen defense that can become aberrantly derepressed during tissue homeostasis to contribute to multiple types of tissue damage and disease. While formation of the necrosome kinase signaling complex containing RIPK1, RIPK3, and MLKL has been extensively characterized, additional mechanisms of its regulation and effector functions likely remain to be discovered. We screened 19,883 mouse protein-coding genes by CRISPR/Cas9-mediated gene knockout for resistance to cytokine-induced necroptosis and identified 112 regulators and mediators of necroptosis, including 59 new candidate pathway components with minimal or no effect on cell growth in the absence of necroptosis induction. Among these, we further characterized the function

SUBMITTER: Callow MG 

PROVIDER: S-EPMC5833675 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature